Skylands Capital LLC Has $12.26 Million Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Skylands Capital LLC increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 19.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 156,790 shares of the company's stock after buying an additional 25,815 shares during the period. GE HealthCare Technologies comprises approximately 1.7% of Skylands Capital LLC's holdings, making the stock its 16th largest holding. Skylands Capital LLC's holdings in GE HealthCare Technologies were worth $12,258,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in GEHC. LGT Financial Advisors LLC raised its stake in GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock worth $25,000 after buying an additional 251 shares in the last quarter. Capital Performance Advisors LLP purchased a new position in shares of GE HealthCare Technologies in the 3rd quarter worth approximately $26,000. Ashton Thomas Securities LLC acquired a new stake in GE HealthCare Technologies in the third quarter valued at approximately $26,000. Darwin Wealth Management LLC acquired a new position in shares of GE HealthCare Technologies during the third quarter worth $31,000. Finally, Continuum Advisory LLC grew its stake in GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company's stock worth $31,000 after buying an additional 168 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Down 1.4 %

GE HealthCare Technologies stock traded down $1.31 during trading on Thursday, reaching $89.40. The stock had a trading volume of 3,926,125 shares, compared to its average volume of 2,852,535. The stock has a market cap of $40.88 billion, a PE ratio of 20.65, a P/E/G ratio of 3.19 and a beta of 1.15. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The business has a 50 day moving average price of $85.76 and a 200 day moving average price of $86.05. GE HealthCare Technologies Inc. has a 52-week low of $74.51 and a 52-week high of $94.80.

Remove Ads

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the stock. Wells Fargo & Company boosted their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a report on Friday, February 14th. Jefferies Financial Group upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their target price for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, Citigroup raised their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a report on Thursday, February 13th. One analyst has rated the stock with a sell rating, three have issued a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of "Moderate Buy" and a consensus target price of $97.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.